Johnson & Johnson said Monday that it had made progress on a vaccine to prevent Covid-19 and that the product could be ready in early 2021.

The New Brunswick, N.J., company selected a lead candidate for the vaccine from the constructs it had been working on, and said human trials would begin by September at the latest. It said it could get approval under an emergency-use authorization to make the vaccine widely available early next year.

Read More